Tech Update: A new approach to Alzheimer’s and proof that video calls are exhausting
Small Canadian biotech start-up Treventis is playing in the big leagues. The Toronto company just secured a partnership with Takeda, Japan’s largest drug maker, to help develop a new therapy for Alzheimer’s. There’s still uncertainty around the causes of Alzheimer’s, but misfolding of a protein called tau is thought to play an important role. It is believed […]